EP4185376A4 - System and method for preventing or treating alzheimer's and other neurodegenerative diseases - Google Patents

System and method for preventing or treating alzheimer's and other neurodegenerative diseases Download PDF

Info

Publication number
EP4185376A4
EP4185376A4 EP21854336.1A EP21854336A EP4185376A4 EP 4185376 A4 EP4185376 A4 EP 4185376A4 EP 21854336 A EP21854336 A EP 21854336A EP 4185376 A4 EP4185376 A4 EP 4185376A4
Authority
EP
European Patent Office
Prior art keywords
preventing
neurodegenerative diseases
treating alzheimer
alzheimer
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP21854336.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP4185376A1 (en
Inventor
Jeffrey K. LUTTRULL
David B. Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ojai Retinal Technology LLC
Original Assignee
Ojai Retinal Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/984,486 external-priority patent/US10894169B2/en
Application filed by Ojai Retinal Technology LLC filed Critical Ojai Retinal Technology LLC
Publication of EP4185376A1 publication Critical patent/EP4185376A1/en
Publication of EP4185376A4 publication Critical patent/EP4185376A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
    • A61N1/403Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals for thermotherapy, e.g. hyperthermia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • A61N5/022Apparatus adapted for a specific treatment
    • A61N5/025Warming the body, e.g. hyperthermia treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP21854336.1A 2020-08-04 2021-06-07 System and method for preventing or treating alzheimer's and other neurodegenerative diseases Withdrawn EP4185376A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/984,486 US10894169B2 (en) 2012-05-25 2020-08-04 System and method for preventing or treating Alzheimer's and other neurodegenerative diseases
PCT/US2021/036128 WO2022031362A1 (en) 2020-08-04 2021-06-07 System and method for preventing or treating alzheimer's and other neurodegenerative diseases

Publications (2)

Publication Number Publication Date
EP4185376A1 EP4185376A1 (en) 2023-05-31
EP4185376A4 true EP4185376A4 (en) 2023-11-15

Family

ID=80117611

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21854336.1A Withdrawn EP4185376A4 (en) 2020-08-04 2021-06-07 System and method for preventing or treating alzheimer's and other neurodegenerative diseases

Country Status (7)

Country Link
EP (1) EP4185376A4 (https=)
JP (1) JP2023544080A (https=)
CN (1) CN116322901A (https=)
AU (1) AU2021321214A1 (https=)
BR (1) BR112023001701A2 (https=)
CA (1) CA3187662A1 (https=)
WO (1) WO2022031362A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114818412B (zh) * 2022-03-18 2022-09-27 北京航空航天大学 一种人脑受电磁辐射的高精度计算方法
KR102787223B1 (ko) * 2022-07-15 2025-03-25 연세대학교 산학협력단 Rf 신호를 통한 질병 원인물질 중합체 분해 장치
CN118761303B (zh) * 2024-09-09 2025-01-07 山东数字人科技股份有限公司 一种基于质点弹簧的膜性薄层组织之间的黏滞力仿真方法
CN119158170A (zh) * 2024-09-09 2024-12-20 重庆大学 基于脉冲电场改善大脑认知能力的装置及应用和穿戴设备

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9014801B2 (en) * 2008-03-19 2015-04-21 The Board Of Trustees Of The University Of Illinois Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response
US20170232269A1 (en) * 2012-05-25 2017-08-17 Ojai Retinal Technology, Llc Process for providing protective therapy for biological tissues or fluids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004321249A (ja) * 2003-04-21 2004-11-18 Matsushita Electric Works Ltd 脳機能活性化装置及び該方法
US20150018667A1 (en) * 2012-01-30 2015-01-15 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Promoting transcranial direct current stimulation or transcranial magnetic stimulation using temperature-induced synaptic modulation
US9962291B2 (en) 2012-05-25 2018-05-08 Ojai Retinal Technology, Llc System and process for neuroprotective therapy for glaucoma
US9333371B2 (en) * 2012-11-01 2016-05-10 Seminex Corporation Variable intensity laser treatments of the skin
WO2014164924A1 (en) * 2013-03-11 2014-10-09 NeuroEM Therapeutics, Inc. Electromagnetic treatment of brian and body disorders
US11813472B2 (en) * 2013-03-11 2023-11-14 NeuroEM Therapeutics, Inc. Systems for sensing proper emitter array placement
US9999772B2 (en) * 2014-04-03 2018-06-19 Pacesetter, Inc. Systems and method for deep brain stimulation therapy
CA3030483A1 (en) * 2016-08-09 2018-02-15 Ojai Retinal Technology, Llc Process for providing protective therapy for biological tissues or fluids

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9014801B2 (en) * 2008-03-19 2015-04-21 The Board Of Trustees Of The University Of Illinois Electromagnetic field therapy delays cellular senescence and death by enhancement of the heat shock response
US20170232269A1 (en) * 2012-05-25 2017-08-17 Ojai Retinal Technology, Llc Process for providing protective therapy for biological tissues or fluids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022031362A1 *

Also Published As

Publication number Publication date
JP2023544080A (ja) 2023-10-20
AU2021321214A1 (en) 2023-02-23
EP4185376A1 (en) 2023-05-31
CA3187662A1 (en) 2022-02-10
WO2022031362A1 (en) 2022-02-10
CN116322901A (zh) 2023-06-23
BR112023001701A2 (pt) 2023-03-28

Similar Documents

Publication Publication Date Title
EP4185376A4 (en) System and method for preventing or treating alzheimer's and other neurodegenerative diseases
EP4087589A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE DISEASES
EP4221838A4 (en) Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseases
EP3927710A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE
EP4188390A4 (en) ATXN2 RNAI COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING ATXN2-ASSOCIATED NEURODEGENERATIVE DISEASES
EP4185333A4 (en) COMPOSITION AND METHOD FOR TREATING EYE DISEASES
EP4188368A4 (en) Compositions and methods for treating diseases and disorders
EP3986439A4 (en) COMPOSITIONS AND METHODS USEFUL IN THE TREATMENT OF BRAIN DISEASES
EP4516305A4 (en) METHOD AND COMPOSITION FOR PREVENTING OR TREATMENT OF MYOPIA
EP3990018A4 (en) METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER’S DISEASE
EP4178604A4 (en) COMPOSITIONS AND METHODS USEFUL FOR THE PREVENTION AND/OR TREATMENT OF DISEASE IN MAMMALS
EP4097236A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES
EP3945077C0 (en) BIOSOLID TREATMENT PROCESS AND SYSTEM
EP3966336A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND ANIMAL AND WHOLE CELL MODELS FOR THE IDENTIFICATION OF EFFECTIVE AGENTS FOR THE TREATMENT THEREOF
EP4188346A4 (en) NOBILETINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF COVID-19 AND RELATED PATHOLOGIES
EP4034109A4 (en) Method and composition for the treatment of disease
EP4028038A4 (en) PEPTIDE COMPOSITIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE
EP4518924A4 (en) SYSTEM AND METHOD FOR TREATMENT OF PREMATURE FETUSES
EP4395752A4 (en) METHODS FOR THE TREATMENT OF CB1-, TRPA1-, AND TRPV1-DEPENDENT CONDITIONS
EP4442273A4 (en) METHOD FOR THE PREVENTION AND/OR TREATMENT OF THROMBOEMBOLIC DISEASES
EP4426349A4 (en) METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE
EP4440566A4 (en) METHODS FOR TREATING AGITATION AND OTHER BEHAVIORAL SYMPTOMS ASSOCIATED WITH DEMENTIA
EP4103177A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF EYE DISEASES
EP4175643A4 (en) COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF
EP4308116A4 (en) METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230222

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20231016

RIC1 Information provided on ipc code assigned before grant

Ipc: A61N 5/04 20060101ALI20231011BHEP

Ipc: A61N 1/40 20060101AFI20231011BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250103